Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 7
Submit an article Journal homepage
2,000
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models

Mareike GreesSkin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyView further author information
,
Adi Sharbi-YungerDepartment of Immunology, Weizmann Institute of Science, Rehovot, IsraelView further author information
,
Christos EvangelouSkin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyORCID Iconhttp://orcid.org/0000-0002-1618-9448View further author information
ORCID Icon,
Daniel BaumannDivision of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, GermanyORCID Iconhttp://orcid.org/0000-0003-4484-9973View further author information
ORCID Icon,
Gal CafriDepartment of Immunology, Weizmann Institute of Science, Rehovot, IsraelView further author information
,
Esther TzehovalDepartment of Immunology, Weizmann Institute of Science, Rehovot, IsraelView further author information
,
Stefan B. EichmüllerGMP and T cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyORCID Iconhttp://orcid.org/0000-0002-3497-6904View further author information
ORCID Icon,
Rienk OffringaDivision of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, GermanyView further author information
,
Jochen UtikalSkin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyView further author information
,
Lea EisenbachDepartment of Immunology, Weizmann Institute of Science, Rehovot, IsraelView further author information
&
Viktor UmanskySkin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, GermanyCorrespondence[email protected]
View further author information
 show all
Article: e1445457 | Received 11 Jan 2018, Accepted 20 Feb 2018, Published online: 26 Mar 2018

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now

Articles from other publishers (12)

Xintao Cen, Mengna Li, Amin Yao, Yue Zheng & Wei Lai. (2023) Immune infiltration and clinical significance analyses of the cancer‐associated fibroblast‐related signature in skin cutaneous melanoma. The Journal of Gene Medicine.
Crossref
Meng Zhang, Tingting Xia, Fengqin Lin, Jiang Yu, Ying Yang, Wei Lei & Tao Zhang. (2023) Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm. Transplant Immunology 76, pages 101766.
Crossref
Xiaolong Li, Shijie Ma, Ting Gao, Yaping Mai, Zhihua Song & Jianhong Yang. (2022) The main battlefield of mRNA vaccine – Tumor immune microenvironment. International Immunopharmacology 113, pages 109367.
Crossref
María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Gabriel Cabrera, Elba Mónica Vermeulen, Luis de la Cruz-Merino & Victor Sánchez-Margalet. (2022) The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells. Frontiers in Immunology 13.
Crossref
Xiaojing Xu, Minfeng Gan, Youzhen Ge, Cheng Yi, Tianyun Feng, Mengjie Liu, Cenhao Wu, Xiang Chen, Weidong Zhang, Lixiang Zhao & Jun Zou. (2021) Multifaceted glycoadjuvant@AuNPs inhibits tumor metastasis through promoting T cell activation and remodeling tumor microenvironment. Journal of Nanobiotechnology 19:1.
Crossref
David Hongo, Pingping Zheng, Suparna Dutt, Rahul D. Pawar, Everett Meyer, Edgar G. Engleman & Samuel Strober. (2021) Identification of Two Subsets of Murine DC1 Dendritic Cells That Differ by Surface Phenotype, Gene Expression, and Function. Frontiers in Immunology 12.
Crossref
João Calmeiro, Mylène A. Carrascal, Adriana Ramos Tavares, Daniel Alexandre Ferreira, Célia Gomes, Maria Teresa Cruz, Amílcar Falcão & Bruno Miguel Neves. (2021) Pharmacological combination of nivolumab with dendritic cell vaccines in cancer immunotherapy: An overview. Pharmacological Research 164, pages 105309.
Crossref
Jichang Han, Nikhil Khatwani, Tyler G. Searles, Mary Jo Turk & Christina V. Angeles. (2020) Memory CD8+ T cell responses to cancer. Seminars in Immunology 49, pages 101435.
Crossref
Yue Shi, Xiaoping Men, Xueting Li, Zhicun Yang & Hongjuan Wen. (2020) Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinoma. International Immunopharmacology 82, pages 106351.
Crossref
Jing-Bo Wang, Xue Huang & Fu-Rong Li. (2019) Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives. Cancer Communications 39:1, pages 43.
Crossref
Leiming Xia, Yi Wang, Tan Li, Xueying Hu, Qian Chen, Liu Liu, Beilei Jiang, Caixin Li, Hua Wang, Siying Wang, Guanghua Yang & Yangyi Bao. (2019) The clinical study on treatment of CD19‐directed chimeric antigen receptor‐modified T cells in a case of refractory Richter syndrome. Cancer Medicine 8:6, pages 2930-2941.
Crossref
Takashi Inozume, Toshiyuki Tsunoda, Takashi Morisaki, Kazutoshi Harada, Seiji Shirasawa & Tatsuyoshi Kawamura. (2018) Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell line. The Journal of Dermatology 45:12, pages 1434-1439.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.